(Focus on Boao) According to the industry: China's vaccine is effective against new coronavirus variants
China News Agency, Boao, April 20 (Reporter Yin Haiming) "At present, the impact of our vaccine on variant strains can still be controlled." State Council Joint Prevention and Control Mechanism Scientific Research Group Vaccine R&D Team Leader, National Health Commission Zheng Zhongwei, director of the Medical and Health Technology Development Research Center, said at the 2021 annual meeting of the Boao Forum for Asia on the 20th.
When answering questions about the effectiveness of Chinese vaccines against new coronavirus variants, Zheng Zhongwei said that starting from the first variant, the scientific research team has specifically arranged continuous tracking and vaccine research and development work for variants, and has been following up the vaccine for all variants. The role of strains and the comparison work.
Yin Weidong, Chairman and CEO of China Kexing Holding Biotechnology Co., Ltd., said that China chose different countries for the third phase of the vaccine, and he anticipated that the virus might mutate.
The vaccine protection rate obtained now is obtained under different strains, and the protection effect is good, reaching the standard of the World Health Organization.
The Chilean Ministry of Health announced on April 16 the results of a real-world study on the protective effects of China's Coxing New Crown vaccine in the country.
Studies have shown that the vaccine is 67% effective in preventing symptomatic infections 14 days after the second dose.
Chile launched a nationwide large-scale vaccination of the new crown vaccine on February 3.
As of the 15th of this month, 7.66 million people in Chile have been vaccinated against the new crown vaccine. The total number of doses in the country is 12.93 million, of which about nine are the new crown vaccines for China's Kexing.
On April 20, the "New Crown Vaccine Supply and Availability" sub-forum of the Boao Forum for Asia 2021 Annual Conference was held in Boao, Hainan Province. Yin Weidong, Chairman and CEO of Kexing Holding Biotechnology Co., Ltd. attended and participated in the discussion.
Photo by China News Agency reporter Hou Yu
Yin Weidong said that Chile already has a mutated virus, and the Chinese vaccine has achieved a good protective effect.
Now we have obtained the virus mutation British strain, South Africa strain, Brazil strain, in the laboratory, the Chinese vaccine can neutralize this virus.
More importantly, no matter which technical route in China, vaccine research after virus mutation is now being done.
A virus mutation is raging in any country, and we can provide it with a vaccine faster than it is now.
Regarding the supply and availability of vaccines, which are of wide concern, Yin Weidong said that Kexing will continue to strengthen research and production cooperation with countries around the world. Based on the existing four cooperative countries, it plans to select more countries for vaccine cooperation as soon as possible. Serve more people.
"There is no doubt that we need more international cooperation." Boao Forum for Asia Advisory Committee and Chairman of AstraZeneca, Leif Johansson, said that the demand for vaccines is huge and the production capacity is limited. If only some people are vaccinated, the world is actually unsafe. "Now There is a so-called'vaccine nationalism', which I totally disagree with." (End)